Давид Цанген

Должность: Эндокринолог, педиатр
Языки: Английский, Иврит
Принимает: детей и взрослых

Профессор Давид Цанген.

Специализация

Специалист в области детской эндокринологии.

Области клинических интересов: 

  • сахарный диабет у детей
  • нарушения функций щитовидной железы.

Научные публикации

Parental awareness and dental health behavior of children with congenital heart disease, with diabetes mellitus, or undergoing anti-cancer treatment, compared to healthy children
Accurate Prediction of Children's Target Height from Their Mid-Parental Height
Long-term therapy with CFTR modulators consistently improves glucose metabolism in adolescents and adults with cystic fibrosis
Characterization of 35 novel NR5A1/SF-1 variants identified in individuals with atypical sexual development: The SF1next study
Clinical and genetic characteristics of a large international cohort of individuals with rare NR5A1/SF-1 variants of sex development
Spleen function is reduced in individuals with NR5A1 variants with or without a difference of sex development: a cross-sectional study
Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children
Loss of function of FIGNL1, a DNA damage response gene, causes human ovarian dysgenesis
Growth hormone therapy for children with Duchenne muscular dystrophy and glucocorticoid induced short stature
ISPAD Clinical Practice Consensus Guidelines 2022: Ramadan and other religious fasting by young people with diabetes
The utility of glucose area under the curve from the oral glucose tolerance test as a screening tool for cystic fibrosis-related diabetes
Correction to: Early exposures and inherent factors in premature newborns are associated with type 1 diabetes
Youth-onset type 2 diabetes in Israel: A national cohort
Early exposures and inherent factors in premature newborns are associated with type 1 diabetes
Nucleoporin107 mediates female sexual differentiation via Dsx
Characterization of the Oral Microbiome Among Children With Type 1 Diabetes Compared With Healthy Children
Eligibility for growth hormone therapy in children born small for gestational age is substantially lower than expected
Aldosterone synthase (CYP11B2) deficiency among Palestinian infants: Three novel variants and genetic heterogeneity
NKX2-2 Mutation Causes Congenital Diabetes and Infantile Obesity With Paradoxical Glucose-Induced Ghrelin Secretion
A Unique Presentation of XY Gonadal Dysgenesis in Frasier Syndrome due to WT1 Mutation and a Literature Review
The novel founder homozygous V225M mutation in the HSD17B3 gene causes aberrant splicing and XY-DSD
Birth during the moderate weather seasons is associated with early onset of type 1 diabetes in the Mediterranean area
The novel R211Q POP1 homozygous mutation causes different pathogenesis and skeletal changes from those of previously reported POP1-associated anauxetic dysplasia
Primary Ovarian Insufficiency Nationwide Incidence Rate and Etiology Among Israeli Adolescents
Somatic growth in cystic fibrosis
Adrenal function in cystic fibrosis
Type 1 Diabetes Mellitus (Juvenile Diabetes) - A Review for the Pediatric Oral Health Provider
Analysis of the genetic basis of height in large Jewish nuclear families
Liraglutide in Children and Adolescents with Type 2 Diabetes
BRCA2 in Ovarian Development and Function. Reply
Combined Gestational Age- and Birth Weight-Adjusted Cutoffs for Newborn Screening of Congenital Adrenal Hyperplasia
Haploseek: a 24-hour all-in-one method for preimplantation genetic diagnosis (PGD) of monogenic disease and aneuploidy
Bilateral Medullary Thyroid Carcinoma in a 3-Year-Old Female Patient with Multiple Endocrine Neoplasia 2A Syndrome Undergoing Prophylactic Thyroidectomy: Should Current Guidelines Be Revised?
Essential Role of BRCA2 in Ovarian Development and Function
Prevalence of early and late prematurity is similar among pediatric type 1 diabetes patients and the general population
Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial
GLP-1-RA Corrects Mitochondrial Labile Iron Accumulation and Improves β-Cell Function in Type 2 Wolfram Syndrome
CFTR potentiator therapy ameliorates impaired insulin secretion in CF patients with a gating mutation
A mutation in the nucleoporin-107 gene causes XX gonadal dysgenesis
Combined mineralocorticoid and glucocorticoid deficiency is caused by a novel founder nicotinamide nucleotide transhydrogenase mutation that alters mitochondrial morphology and increases oxidative stress
Minichromosome maintenance complex component 8 (MCM8) gene mutations result in primary gonadal failure
Congenital hyperinsulinism, neonatal diabetes and the risk of malignancies: an international collaborative study. Preliminary communication
A novel familial mutation in the PCSK1 gene that alters the oxyanion hole residue of proprotein convertase 1/3 and impairs its enzymatic activity
Testicular differentiation factor SF-1 is required for human spleen development
Trends in the incidence of type 1 diabetes among Jews and Arabs in Israel
Long duration of hyperglycemia in the first 96 hours of life is associated with severe intraventricular hemorrhage in preterm infants
Euthyroid submedian free T4 and subclinical hypothyroidism may have a detrimental clinical effect in Down syndrome
A novel severe N-terminal splice site KISS1R gene mutation causes hypogonadotropic hypogonadism but enables a normal development of neonatal external genitalia
Increase in the incidence of type 1 diabetes in Israeli children following the Second Lebanon War
Relative expression of a dominant mutated ABCC8 allele determines the clinical manifestation of congenital hyperinsulinism
Показать ещё 42 статьи Скрыть статьи
Заболевания
Нарушения роста
Остались вопросы?
Напишите нам и мы свяжемся с вами в течение ближайшего времени и ответим на все интересующие вопросы